20:33 EDT 17th March 2018 | BioPortfolio

GIZA VENTURE CAPITAL established in 1992, is a pioneer investor in seed and early-stage technology companies. Giza currently manages four funds totaling about $500 million.Giza has investment professionals with a wealth of expertise and experience in Communications, Semiconductors, Information Technology, Enterprise Software and Life Sciences.
Giza has invested in 82 companies in the sectors of Communications, Information Technology, Enterprise Software and Life Sciences, with 29 exits. Giza's vision in recognizing future technology leaders led to the following winning investments; Olplus (acquired by Intel, Cyota (acquired by RSA), X Technologies (acquired by Guidant), Precise (NASDAQ:PRSE, acquired by Veritas), Oridion (SWX:ORIDN), Zoran (NASDAQ:ZRAN), M-Systems (NASDAQ:FLSH), DSPG (NASDAQ:DSPG), Butterfly (acquired by TI), DSPC (acquired by Intel), Libit


Ramat Aviv Tower 40 Einstein St. , 12 th floor
Tel Aviv


Phone: 972 3 640 2318
Fax: 972 3 640 2319

News Articles [1142 Associated News Articles listed on BioPortfolio]

Scientists Just Found a Hidden Chamber in the Great Pyramid of Giza

Scientists have found a hidden chamber in Egypt’s Great Pyramid of Giza, the first such discovery in the structure since the 19th century and one likely to spark a new surge of interest in the phara...

2016 US Venture Capital Investment into Life Sciences Companies: An Analysis by Evolution Global

In order to elucidate the focus of Venture Capital funding in the Biotechnology sector this year, Evolution Analysts have assessed the deals carried out by the Top 25 US Venture

Codiak closes $76.5mm Series C

Codiak Biosciences Inc. raised $76.5mm through its Series C round to new investors Qatar Investment Authority, Boxer Capital (Tavistock), Sirona Capital, EcoR1 Capital, and Casdin Capital, along with ...

$10M venture capital fund launched by Genesis Innovation

Cultivate(MD) Capital Fund I, a $10 million venture capital fund, was launched by Michigan-based medical device development a -More- 

Renault-Nissan-Mitsubishi Launches a Venture Capital Fund to Invest up to $1 Billion Over Five Years

New entity to act asmaininterface for start-ups, investors and the venture capital ecosystem  Fund prioritizesopeninnovation in new mobility, Read more...

Humanity United launches Working Capital, a $23 million venture fund to invest in ethical ...

SAN FRANCISCO, Jan. 30, 2018/PRNewswire-USNewswire/ -- Working Capital, an early-stage venture fund, launched today with the goal of accelerating supply chain innovations to Read more...

M2P Consulting Introduces Dr. Christoph Lymbersky as New Partner Leading the Venture Capital ...

NEW YORK, Nov. 27, 2017/PRNewswire/ -- Dr. Christoph Lymbersky has joined M2P Consultingas a partner responsible for the Venture and Capital Partners business Read more...

New Venture Fund Closes $102M to Boost Biotech and Medical Device Development

Truffle Capital has raised $102M (€85M), which will be used to support biotech and medical device companies that have the potential to become market leaders. Truffle Capital, founded in 2001 and bas...

PubMed Articles [132 Associated PubMed Articles listed on BioPortfolio]

A Tale of Two Towns: A Comparative Study Exploring the Possibilities and Pitfalls of Social Capital among People Seeking Recovery from Substance Misuse.

Social capital has become an influential concept in debating and understanding the modern world. Within the drug and alcohol sector, the concept of 'recovery capital' has gained traction with research...

Changes in social capital and depressive states of middle-aged adults in Japan.

The present study examines the relationships between changes in bonding and bridging types of social capital and depressive states among middle-aged adults in Japan using a nationally representative s...

Recovery capital pathways: Modelling the components of recovery wellbeing.

In recent years, there has been recognition that recovery is a journey that involves the growth of recovery capital. Thus, recovery capital has become a commonly used term in addiction treatment and r...

The dark side of social capital: A systematic review of the negative health effects of social capital.

There is a growing literature demonstrating the health benefits of social capital (defined as the resources accessed through social connections). However, social capital is also acknowledged to be a "...

Social Capital and Health Among Older Chinese Immigrants: a Cross-Sectional Analysis of a Sample in a Canadian Prairie City.

The objective of this study was to examine the relationship between social capital and health among Chinese immigrants. The sample included 101 older Chinese immigrants aged 60 to 96 who were recruite...

Clinical Trials [45 Associated Clinical Trials listed on BioPortfolio]

Prevalence of NNSH in a Group of Egyptian Children Aged 3-8 Years Old in Giza Governorate: A Cross Sectional Study.

1. Prevalence of non-nutritive sucking habits (NNSH) in a group of Egyptian children aged 3-8 years old in Giza Governorate. 2. Assessment of factors associated with NNSH.

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

Prevalence of Molar Incisor Hypomineralization Among a Group of Egyptian Children in Giza Governorate

- One single operator will assess the prevalence of molar incisor hypomineralization and its Severity among a group of Egyptian children in Giza Governorate .

The Montreal Neighbourhood Networks and Healthy Aging Panel

Social networks, social capital, i.e., network-accessed resources, and neighbourhood environments have been shown associated with a range of health behaviours and conditions, including obe...

"Gait and Balance in Patients With SCFE"

Slipped Capital Femoral Epiphysis (SCFE) treated with one screw in situ fixation results in an altered gait. It is thought that the protraction of the pelvis at the affected side, seen in ...

Companies [1570 Associated Companies listed on BioPortfolio]


GIZA VENTURE CAPITAL established in 1992, is a pioneer investor in seed and early-stage technology companies. Giza currently manages four funds totaling about $500 million.Giza has investment professi...

BVK Bundesverband Deutscher Kapitalbeteiligungsgesellschaften German Private Equity and Venture Capital Association e.V.

Bundesverband Deutscher Kapitalbeteiligungsgesellschaften – German Private Equity and Venture Capital Association e.V. (BVK) is the organisation of German venture capital and private equity companie...

Russian Venture Capital Association

The idea to create Russian Venture Capital Association had been expressed at the December 1996 seminar for EBRD regional venture capital fund managers in St.-Petersburg. The RVCA founding meeting was ...


The EIF's activity is centred upon two areas, venture capital and guarantees: EIF's venture capital instruments consist of equity investments in venture capital funds and business incubators that supp...


David Morgenthaler founded the firm in 1968 after a successful career as an operating executive. After his venture-backed business was sold to an international company, Dave decided that there was a t...

More Information about "GIZA VENTURE CAPITAL" on BioPortfolio

We have published hundreds of GIZA VENTURE CAPITAL news stories on BioPortfolio along with dozens of GIZA VENTURE CAPITAL Clinical Trials and PubMed Articles about GIZA VENTURE CAPITAL for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GIZA VENTURE CAPITAL Companies in our database. You can also find out about relevant GIZA VENTURE CAPITAL Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record